Track the Molecular Partners AG share price and the full management transaction log of the company, a listed issuer based in Switzerland. Shares are quoted on the CH market, under the supervision of SIX SER. Operating in the Health Care sector, Molecular Partners AG has recorded 6 insider filings. Market capitalisation: €118.2m. The latest transaction was disclosed on 2 April 2026 (Sale). The full history is free.
6
Insider Decl.
n/a
Thresholds
€32,994
1 ops.
Buy Volume
€497,857
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Molecular Partners AG Buy (bullish), based on 2 analysts. Average price target: CHF 9.00.
26Σ signal
Buys €32,994€497,857 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 April 2026
Declarations6 total
●
Anonymous (Executive member of the board of directors / member of senior management)
Executive member of the board of directors / member of senior management·Executives·
10,000 shares@ CHF 3.17610.026% mcap100.0% of flowISINISIN CH0256379097SIX:T1NB100071
6 of 6 declarations
Acerca de Molecular Partners AG
Molecular Partners AG es una empresa biofarmacéutica suiza centrada en el desarrollo de terapias basadas en proteínas. Cotiza en la bolsa de valores suiza XSWX.